- NEUTRAL
Quarterly Revenue Humacyte Inc Sep-2024 Quarterly Revenue is $0 Million which is growth of 0% YoY.
- NEGATIVE
Quarterly Net Profit Humacyte Inc Sep-2024 Quarterly Net Profit is $-39 Million which is growth of -50.8% YoY.
Humacyte Inc - Forecaster
Forecaster Analyst Estimates for Humacyte Inc share price target, revenues, EPS, net income and more
Humacyte Inc - Quarterly Results
Humacyte Inc quarterly, revenue, profit, P&L - 13 Quarters history
Nested row level
Base Level
Reported Types
Originally Reported
Column Order
New to Old
Cell Coloring
YoY
Nested row level
Base Level
Export
Add metric to table
Search...
Humacyte Inc - Competitors/Peers
Humacyte Inc Competitor comparison and performance within its industry
Humacyte Inc - Annual Results
Humacyte Inc annual result as of Dec 2023, revenue, profit, P&L, Margins and history
Nested row level
Base Level
Reported Types
Originally Reported
Column Order
New to Old
Cell Coloring
Enable
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEUTRAL
Annual Revenue Humacyte Inc Annual Revenue is $0 Million which is growth of 0% YoY.
- NEGATIVE
Annual Net Profit Humacyte Inc Annual Net Profit is $-111 Million which is growth of -825.8% YoY.
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
14.5%
2Y CAGR
9.2%
3Y CAGR
14.5%
Humacyte Inc - Balance Sheet
Humacyte Inc balance sheet values as of Dec 2023 assets, liabilities, reserves, borrowings and history
Nested row level
Base Level
QuarterlyAnnual
Reported Types
Originally Reported
Column Order
New to Old
Cell Coloring
Enable
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Total Shareholders Fund Humacyte Inc Dec-2023 Total Shareholders Fund is $14 Million which is growth of -88.4% YoY.
- NEGATIVE
Total Assets Humacyte Inc Dec-2023 Total Assets is $128 Million which is growth of -37.2% YoY.
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-37.2%
2Y CAGR
-33.1%
3Y CAGR
6.3%
Total Current Liabilities Ann.
1Y CHG
-6.1%
2Y CAGR
28.8%
3Y CAGR
18%
Total ShareHolders Funds Ann.
1Y CHG
-88.4%
2Y CAGR
-66.6%
Humacyte Inc - Financial Ratios
Humacyte Inc ROE, ROCE, book value, and debt to equity ratio as of Dec 2023 and 10 year history
Nested row level
Base Level
Reported Types
Originally Reported
Column Order
New to Old
Cell Coloring
Enable
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Book Value Per Share Humacyte Inc Book Value Per Share is $-0 which is growth of -143.1% YoY.
- POSITIVE
ROE Humacyte Inc ROE is -170% which is growth of 159.8% YoY.
Add metric to table
Search...
Current Ratio Ann.
1Y CHG
-43%
2Y CAGR
-53.5%
3Y CAGR
6.7%
Humacyte Inc - Cash Flow
Humacyte Inc cash flow with net cash flow, operating, investing and financing cash flows as of Dec 2023 and 10 year history
Nested row level
Base Level
QuarterlyAnnual
Reported Types
Originally Reported
Column Order
New to Old
Cell Coloring
Enable
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Humacyte Inc Cash From Operating Activity is $-73 Million which is growth of -3.1% YoY.
- NEGATIVE
Net Cash Flow Humacyte Inc Net Cash Flow is $-69 Million which is growth of -1.8% YoY.
Add metric to table
Search...
Cash from Financing Act. Ann.
2Y CAGR
-87%
3Y CAGR
28.9%